Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2012 - 2013)
Jazz Pharmaceuticals (JAZZ) posted quarterly Gains from Investment Securities of -$12.9 million for Q3 2013, down 1333.33% year-over-year from $1.0 million in Q3 2012, and down 63.29% quarter-over-quarter from -$7.9 million in Q2 2013.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2012 - 2013) Analysis & Trends
Jazz Pharmaceuticals' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$12.9 million for Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | -12.90 Mn |
| Jun 30, 2013 | -7.90 Mn |
| Sep 30, 2012 | -900,000.00 |